alexa Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation: US evaluation.
Infectious Diseases

Infectious Diseases

Journal of AIDS & Clinical Research

Author(s): Gabrielli E, Ferraioli G, Ferraris L, Riva A, Galli M, , Gabrielli E, Ferraioli G, Ferraris L, Riva A, Galli M,

Abstract Share this page

Abstract Enfuvirtide is a large protein that should be injected subcutaneously to ensure an appropriate absorption. Here we report the case of a transgender HIV-positive patient receiving enfuvirtide with an individualized background regimen of antiretroviral drugs, who had previously undergone liquid silicone oil injections. We performed US scan to detect silicone-free areas for following enfuvirtide injections. US can be useful in the correct management of those patients with liquid silicone oil soft tissue augmentation who require subcutaneously injected drugs.
This article was published in New Microbiol and referenced in Journal of AIDS & Clinical Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version